Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001692444-26-000010

Options or other derivatives

  • Director acquired 6,090 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Soteropoulos Paula Director 2026-05-21 Grant or award · Stock Option (Right to Buy) +6,090 6,090 D: show line 1 in the form
Loading xslF345X06/ownership.xml…